Physiological and pathological roles of Apaf1 and the apoptosome

Journal of Cellular and Molecular Medicine

Volumn 7, Issue 1, 2003, Pages 21-34

  Ferraro, E ^a   Corvaro, M ^a   Cecconi, F ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Apaf1; Apoptosis; Apoptosome; Caspases; Cell death; Neurodegeneration

Indexed keywords

APOPTOSOME; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER; CELL DEATH; CELL FUNCTION; CELL ORGANELLE; DISEASE COURSE; ENZYME ACTIVATION; HUMAN; KNOCKOUT GENE; MITOCHONDRION; NERVE DEGENERATION; NONHUMAN; PATHOLOGY; PHYSIOLOGY; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0141576734     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2003.tb00199.x     Document Type: Review

References (89)

1. Kerr J.F., Wyllie A.H., Currie A.R., Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br J. Cancer, 26: 239-257, 1972
2. Jacobson M.D., Weil M., Raff M.C., Programmed cell death in animal development, Cell, 88: 347-354, 1997
3. Earnshaw W.C., Martins L.M., Kaufmann S.H., Mammalian caspases: structure, activation, substrates, and functions during apoptosis, Annu. Rev. Biochem., 68: 383-424, 1999
4. Martinou J.C., Green D.R., Breaking the mitochondrial barrier, Nat. Rev. Mol. Cell Biol., 2: 63-67, 2001
5. Zamzami N., Kroemer G., The mitochondrion in apoptosis: how Pandora's box opens, Nat. Rev. Mol. Cell. Biol., 2: 67-71, 2001
6. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang X., Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade, Cell, 91: 479-489, 1997
7. Acehan D., Jiang X., Morgan D.G., Heuser J.E., Wang X., Akey C.W., Three-dimensional structure of the apoptosome. Implications for assembly, procaspase-9 binding, and activation, Mol. Cell, 9: 423-432, 2002
8. Riedl S.J., Renatus M., Schwarzenbacher R., Zhou Q., Sun C., Fesik S.W., Liddington R.C., Salvesen G.S., Structural basis for the inhibition of caspase-3 by XIAP, Cell, 104: 791-800, 2001
9. Bratton S.B., Walker G., Srinivasula S.M., Sun X.M., Butterworth M., Alnemri E.S., Cohen G.M., Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes, EMBO J., 20: 998-1009, 2001
10. Verhagen A.M., Ekert P.G., Pakusch M., Silke J., Connolly L.M., Reid G.E., Moritz R.L., Simpson R.J., Vaux D.L., Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins, Cell, 102: 43-53, 2000
11. Verhagen A.M., Silke J., Ekert P.G., Pakusch M., Kaufmann H., Connolly L.M., Day C.L., Tikoo A., Burke R., Wrobel C., Moritz R.L., Simpson R.J., Vaux D.L., HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins, J. Biol. Chem., 277: 445-454, 2002
12. Saleh A., Srinivasula S.M., Balkir L., Robbins P.D., Alnemri E.S., Negative regulation of the Apaf-1 apoptosome by Hsp70, Nat. Cell. Biol., 2: 476-483, 2000
13. Pandey P., Saleh A., Nakazawa A., Kumar S., Srinivasula S.M., Kumar V., Weichselbaum R., Nalin C., Alnemri E.S., Kufe D., Kharbanda S., Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90, EMBO J., 19: 4310-4322, 2000
14. Bruey J.M., Ducasse C., Bonniaud P., Ravagnan L., Susin S.A., Diaz-Latoud C., Gurbuxani S., Arrigo A.P., Kroemer G., Solary E., Garrido C., Hsp27 negatively regulates cell death by interacting with cytochrome c, Nat. Cell. Biol., 2: 645-652, 2000
15. Cecconi F., Apaf1 and the apoptotic machinery, Cell Death Differ., 6: 1087-1098, 1999
16. Cecconi F., Alvarez-Bolado G., Meyer B.I., Roth K.A., Gruss P., Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development, Cell., 94(6): 727-37, 1998
17. Sperandio S., de Belle I., Bredesen D.E., An alternative, nonapoptotic form of programmed cell death, Proc. Natl. Acad. Sci. USA, 97: 14376-81, 2000
18. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., Kroemer G., Molecular characterization of mitochondrial apoptosis-inducing factor., Nature, 397: 441-6, 1999
19. Honarpour N., Gilbert S.L., Lahn B.T., Wang X., Herz J., Apaf-1 deficiency and neural tube closure defects are found in fog mice, Proc. Natl. Acad. Sci. USA, 98: 9683-9687, 2001
20. Moreno S., Ferraro E., Eckert S., Cecconi F., Apaf1 reduced expression levels generate a mutant phenotype in adult brain and skeleton, Cell Death Differ., 9: 340-342, 2002
21. Vousden K.H., p53: death star, Cell, 103: 691-694, 2000
22. Macleod K., Tumor suppressor genes, Curr. Op. in Genet. Dev., 10: 81-93, 2000
23. Soengas M.S., Alarcon R.M., Yoshida H., Giaccia A.J., Hakem R., Mak T.W., Lowe S.W., Apaf-1 and Caspase-9 in p53-dependent apoptosis and tumor inhibition, Science, 284: 156-159, 1999
24. Guo Z., Yikang S., Yoshida H., Mak T.W., Zacksenhaus E., Inactivation of retinoblastoma tumor suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis, Cancer Res., 61: 8395-8400, 2001
25. Kimura M., Kurukawa T., Abe T., Yatsuoka T., Youssef E.M., Yokoyama T. et al., Identification of two common regions of allelic loss in chromosome arm 12q in human pancreatic cancer, Cancer Res., 58: 2456-2460, 1998
26. Bala S., Oliver H., Renault B., Montgomery K., Dutta S., Rao P., Houldsworth J., Kucherlapati R., Wang X., Chaganti R.S.K., Murty V.V.V.S., Genetic analysis of the APAF1 Gene in male germ cells tumors, Genes Chromosomes Cancer, 28: 258-268, 2000
27. Yamamoto H., Gil J., Schwartz S. jr, Perucho M., Frameshift mutations in Fas, Apaf-1, and Bcl-10 in gastrointestinal cancer of the microsatellite mutator phenotype, Cell Death Differ., 7: 238-239, 2000
28. Soengas M.S., Capodieci P., Polsky D., Mora J., Esteller M., Opitz-araya X., McCombie R., Herman J.G., Gerald W.L., Lazebnik Y.A., Cordò n-cardò C., Lowe S.W., Inactivation of the apoptosis effector Apaf-1 in malignant melanoma, Nature, 409: 207-211, 2001
29. Wolf B.B., Schuler M., Li W., Eggers-Sedlet B., Lee W., Tailor P., Fitzgerald P., Mills G.B., Green D.R., Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity, J Biol Chem., 276: 34244-34251, 2001
30. Liu J.R., Opipari A.W., Tan L., Jiang Y., Zhang Y., Tang H., Nunez G., Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance, Cancer Res., 62: 924-931, 2002
31. Gilberston R., Paediatric embryonic brain tumors: biological and clinical relevance of molecoular genetics abnormalities, Eur J. Cancer, 38: 675-685, 2002
32. Pomeroy S.L., Tamayo P., Gaasenbeek M., Sturla L.M., Angelo M., McLaughlin M.E., Kim J.Y.H., Goumnerova L.C., Black P.M. et al., Prediction of central nervous system embryonal tumour outcome based on gene expression, Nature, 415: 436-442, 2002
33. Teitz T., Wei T., Liu D., Valentine V., Valentine M., Grenet J., Lahti J.M., Kidd V. J., Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplyfied MYCN, Oncogene, 21: 1848-1858, 2002
34. Fortin A., Cregan S.P., MacLaurin J.G., Kushwaha N., Hickman E.S., Thompson C.S., Hakim A., Albert P.R., Cecconi E, Helin K., Park D.S., Slack R.S., APAF1 is a key trascriptional target for p53 in the regulation of the neuronal cell death., J. Cell Biol., 155: 207-16, 2001
35. Moroni M.C., Hickman E.S., Lazzarini Denchi E., Caprara G., Colli E., Cecconi F., Muller H., Helin K., Apaf-1 is a trascriptional target for e2f and p53, Nature Cell Biol., 3: 552-558, 2001
36. Kannan K., Kaminski N., Rechavi G., Jacob-Hirsch J., Amariglio N., Givol D., DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1, Oncogene, 20: 3449-3455, 2001
37. Rozenfeld-granot G., Krishnamurthy J., Kannan K., Toren A., Amariglio N., Givol D., Rechavi G., A positive feedback mechanism in the trascriptional activation of Apaf-1 by p53 and the coactivator Zac-1, Oncogene, 21: 1469-1476, 2002
38. Coldwell M.J., Mitchell S.A., Stoneley M., MacFarlane M., Willis A.E., Initiation of Apaf-1 translation by internal ribosome entry, Oncogene, 19: 899-905, 2000
39. Mitchell S.A., Brown E.C., Coldwell M.J., Jackson R.J., Willis A.E., Protein factor requirements of the Apaf1 internal ribosome entry segment: roles of polypyrimidine tract binding protein and upstream of N-ras, Mol. Cell Biol., 21: 3364-3374, 2001
40. Chauhan D., Hideshima T., Rosen S., Reed J.C., Kharbanda S., Anderson K.C., Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells, J. Biol. Chem., 276: 24453-24456, 2001
41. Shinoura N., Sakurai S., Asai A., Kirino T., Hamada H., Over-expression of APAF-1 and caspase-9 augments radiation-induced apoptosis in U-373MG glioma cells, Int. J. Cancer., 93: 252-261, 2001
42. Mizutani Y., Sato N., Kawauchi A., Nonomura N., Fukushima M., Miki T., Cisplatin-induced in vivo differentiation of human embryonal carcinoma, BJU international, 89: 454-458, 2002
43. Jones P.A., Death and methilation, Nature, 409: 141-144, 2001
44. Troy C.M., Salvesen G.S., Caspases on the brain, J. Neurosci. Res., 69: 145-50, 2002
45. Weidemann A., Paliga K., Durrwang U., Reinhard F.B., Schuckert O., Evin G., Masters C.L., Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases, J. Biol. Chem., 274: 5823-5829, 1999
46. Wellington C.L., Ellerby L.M., Hackam A.S., Margolis R.L., Trifiro M.A., Singaraja R., McCutcheon K., Salvesen G.S., Propp SS., Bromm M., Rowland K.J., Zhang T., Rasper D., Roy S., Thornberry N., Pinsky L., Kakizuka A., Ross C.A., Nicholson D.W., Bredesen D.E., Hayden M.R., Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract, J. Biol. Chem., 273: 9158-9167, 1998
47. Gervais F.G., Xu D., Robertson G.S., Vaillancourt J.P., Zhu Y., Huang J., LeBlanc A., Smith D., Rigby M., Shearman M.S., Clarke E.E., Zheng H., Van Der Ploeg L.H., Ruffolo S.C., Thornberry N.A., Xanthoudakis S., Zamboni R.J., Roy S., Nicholson D.W., Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation, Cell, 97: 395-406, 1999
48. Pellegrini L., Passer B.J., Tabaton M., Ganjei J.K., D'Adamio L., Alternative, non-secretase processing of Alzheimer's beta-amyloid precursor protein during apoptosis by caspase-6 and -8, J. Biol. Chem., 274: 21011-6, 1999
49. Tanzi M., Bellelli E., Benaglia G., Cavatorta E., Merialdi A., Mordacci E., Ribero M.L., Tagger A., Verrotti C., Volpicelli A., Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease, Science, 277: 373-376, 1997
50. Lunkes A., Lindenberg K.S., Ben-Haiem L., Weber C., Devys D., Landwehrmeyer G.B., Mandel J.L., Trottier Y., Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions, Mol. Cell., 10: 259-269, 2002
51. Marx J., Neuroscience. New leads on the 'how' of Alzheimer's, Science, 293: 2192-2194, 2001
52. Rohn T.T., Head E., Su J.H., Anderson A.J., Bahr B.A., Cotman C.W., Cribbs D.H., Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease, Am. J. Pathol., 158: 189-198, 2001
53. LeBlanc A., Liu H., Goodyer C., Bergeron C., Hammond J., Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease, J. Biol. Chem., 274: 23426-36, 1999
54. Stadelmann C., Deckwerth T.L., Srinivasan A., Bancher C., Bruck W., Jellinger K., Lassmann H., Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death., Am. J. Pathol., 155: 1459-66, 1999
55. Lu D.C., Rabizadeh S., Chandra S., Shayya R.F., Ellerby L.M., Ye X., Salvesen G.S., Koo E.H., Bredesen D.E., A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor, Nat. Med., 6:397-404, 2000
56. Li M., Ona V.O., Guegan C., Chen M., Jackson-Lewis V., Andrews L.J., Olszewski A.J., Stieg P.E., Lee J.P., Przedborski S., Friedlander R.M., Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model, Science, 288: 335-9, 2000
57. Pasinelli P., Houseweart M.K., Brown R.H. Jr, Cleveland D.W., Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis, Proc. Natl. Acad. Sci. USA, 97: 13901-13906, 2000
58. Sanchez I., Xu C.J., Juo P., Kakizaka A., Blenis J., Yuan J., Caspase-8 is required for cell death induced by expanded polyglutamine repeats, Neuron, 22: 623-633, 1999
59. Jeon B.S., Kholodilov N.G., Oo T.F., Kim S.Y., Tomaselli K.J., Srinivasan A., Stefanis L., Burke R.E., Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra, J. Neurochem., 73: 322-333, 1999
60. Viswanath V., Wu Y., Boonplueang R., Chen S., Stevenson F.F., Yantiri F., Yang L., Beal M.F., Andersen J.K., Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease, J. Neurosci., 21: 9519-28, 2001
61. Love S., Barber R., Wilcock G.K., Neuronal death in brain infarcts in man, Neuropathol. Appl. Neurobiol., 26: 55-66, 2000
62. Nicotera P., Apoptosis and age-related disorders: role of caspase-dependent and caspase-independent pathways, Toxicol. Lett., 127: 189-195, 2002
63. Forloni G., Bugiani O., Tagliavini F., Salmona M., Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments, Mol. Chem. Neuropathol., 28: 163-171, 1996
64. Ivins K.J., Thornton P.L., Rohn T.T., Cotman C.W., Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8, Neurobiol. Dis., 6: 440-449, 1999
65. Uetsuki T., Takemoto K., Nishimura I., Okamoto M., Niinobe M., Momoi T., Miura M., Yoshikawa K., Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein, J. Neurosci., 19: 6955-6964, 1999
66. Kienlen-Campard P., Miolet S., Tasiaux B., Octave J.N., Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis, J. Biol. Chem., 277: 15666-15670, 2002
67. Zhang Y., McLaughlin R., Goodyer C., LeBlanc A., Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons., J. Cell Biol., 156: 519-529, 2002
68. Wei W., Norton D.D., Wang X., Kusiak J.W., Abeta 17-42 in Alzheimer's disease activates JNK and caspase-8 leading to neuronal apoptosis, Brain, 125: 2036-2043, 2002
69. Kim H.S., Lee J.H., Lee J.P., Kim E.M., Chang K.A., Park C.H., Jeong S.J., Wittendorp M.C., Seo J.H., Choi S.H., Suh Y.H., Amyloid beta peptide induces cytochrome c release from isolated mitochondria, Neuroreport, 13: 1989-1993, 2002
70. Allen J.W., Eldadah B.A., Huang X., Knoblach S.M., Faden A.I., Multiple caspases are involved in beta-amyloid-induced neuronal apoptosis, J. Neurosci. Res., 65: 45-53, 2001
71. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A., Yuan J., Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta, Nature, 403:98-103, 2000
72. Troy C.M., Rabacchi S.A., Friedman W.J., Frappier T.F., Brown K., Shelanski M.L., Caspase-2 mediates neuronal cell death induced by beta-amyloid, J. Neurosci., 20: 1386-1392, 2000
73. Morishima Y., Gotoh Y., Zieg J., Barrett T., Takano H., Flavell R., Davis R.J., Shirasaki Y., Greenberg M.E., Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand, J. Neurosci., 21: 7551-7560, 2001
74. Wolozin B., Iwasaki K., Vito P., Ganjei J.K., Lacana E., Sunderland T., Zhao B., Kusiak J.W., Wasco W., D'Adamio L., Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation, Science, 274: 1710-1713, 1996
75. Kim M., Lee H.S., LaForet G., McIntyre C., Martin E.J., Chang P., Kim T.W., Williams M., Reddy P.H., Tagle D., Boyce F.M., Won L., Heller A., Aronin N., DiFiglia M., Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition., J. Neurosci., 19: 964-973, 1999
76. Miyashita T., Matsui J., Ohtsuka Y., Mami U., Fujishima S., Okamura-Oho Y., Inoue T., Yamada M., Expression of extended polyglutamine sequentially activates initiator and effector caspases, Biochem. Biophys. Res. Commun., 257: 724-30, 1999
77. Saudou F., Finkbeiner S., Devys D., Greenberg M.E., Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions, Cell, 95: 55-66, 1998
78. Wellington C.L., Singaraja R., Ellerby L., Savill J., Roy S., Leavitt B., Cattaneo E., Hackam A., Sharp A., Thornberry N., Nicholson D.W., Bredesen D.E., Hayden M.R., Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells, J. Biol. Chem., 275: 19831-8, 2000
79. Gervais F.G., Singaraja R., Xanthoudakis S., Gutekunst C.A., Leavitt B.R., Metzler M., Hackam A.S., Tam J., Vaillancourt J.P., Houtzager V., Rasper D.M., Roy S., Hayden M.R., Nicholson D.W., Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi, Nat. Cell Biol., 4: 95-105, 2002
80. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y., Ona V., Li M., Sarang S., Liu A.S., Hartley D.M., Wu du C., Gullans S., Ferrante R.J., Przedborski S., Kristal B.S., Friedlander R.M., Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice, Nature, 417: 74-78, 2002
81. Guegan C., Vila M., Teissman P., Chen C., Onteniente B., Li M., Friedlander R.M., Przedborski S., Instrumental activation of bid by caspase-1 in a transgenic mouse model of ALS, Mol. Cell Neurosci., 20: 553-562, 2002
82. Mochizuki H., Hayakawa H., Migita M., Shibata M., Tanaka R., Suzuki A., Shimo-Nakanishi Y., Urabe T., Yamada M., Tamayose K., Shimada T., Miura M., Mizuno Y., An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease, Proc. Natl. Acad. Sci. USA, 98: 10918-10923, 2001
83. Yakovlev A.G., Ota K., Wang G., Movsesyan V., Bao W.L., Yoshihara K., Faden A.I., Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury, J. Neurosci., 21: 7439-7446, 2001
84. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., Younkin L., Good M.A., Bliss T.V., Hyman B.T., Younkin S.G., Hsiao K.K., Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice, Nat. Neurosci., 2: 271-276, 1999
85. Carter R.J., Lione L.A., Humby T., Mangiarini L., Mahal A., Bates G.P., Dunnett S.B., Morton A.J., Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation, J. Neurosci., 19: 3248-3257, 1999
86. Hansson O., Petersen A., Leist M., Nicotera P., Castilho R.F., Brundin P., Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity, Proc. Natl. Acad. Sci. USA, 96: 8727-8732, 1999
87. Ivins K.J., Bui E.T., Cotman C.W., Beta-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis, Neurobiol. Dis., 5: 365-378, 1998
88. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P., Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function, Neuron, 15: 961-973, 1995
89. Volbracht C., Leist M., Kolb S.A., Nicotera P., Apoptosis in caspase-inhibited neurons, Mol. Med., 7: 36-48, 2001